Experience

三生国健药业(上海)股份有限公司
• China
• Research Services
• 1 - 100 Employee
• 医学经理

  • Jan 2021 - Present


Allist

• Indonesia
• Furniture and Home Furnishings Manufacturing

• Senior Clinical Analyst

  • Nov 2017 - Apr 2019

  ob contents:  Clinical trial reports for alflutinib mesylate: analyzed pharmacokinetic (PK) data and wrote the report, took statistic analysis of efficacy and safety data of phase Ⅰ&Ⅱ trials and published monthly report, drafted clinical study protocols;  Academic support: searched and analyzed the literatures of EGFR-TKIs and PARP inhibitors;  Pharmacovigilance: reviewed the SAE reports, wrote the study document for case report;  Project management: managed the progression of PK and transporter studies in phase Ⅰ clinical trial, did supported work for clinical project launch. Show less



上海艾力斯医药科技有限公司

• 临床医学高级研究员

  • Nov 2017 - Apr 2019

   甲磺酸艾氟替尼临床试验报告：分析药代动力学（PK）数据并撰写报告，统计分析有效性和安全性数据并撰写月度总结报告，撰写临床研究方案；  临床研究学术支持：负责跟踪查阅国内外三代EGFR-TKIs和PARP抑制剂的学术资料；  药物警戒：审核SAE报告，撰写特殊SAE说明文件；  项目管理：管理项目所涉及的PK实验和转运体实验的进度；支持临床试验启动会的召开  甲磺酸艾氟替尼临床试验报告：分析药代动力学（PK）数据并撰写报告，统计分析有效性和安全性数据并撰写月度总结报告，撰写临床研究方案；  临床研究学术支持：负责跟踪查阅国内外三代EGFR-TKIs和PARP抑制剂的学术资料；  药物警戒：审核SAE报告，撰写特殊SAE说明文件；  项目管理：管理项目所涉及的PK实验和转运体实验的进度；支持临床试验启动会的召开


Shanghai Institute of Materia Medica
• 1 - 100 Employee
• We bought BioCatalyst from Bruker

  • 2011 - 2012